Title: Triptolide attenuates irritable bowel syndrome via inhibiting ODC1
Version: 3 Date: 06 Jun 2023
Reviewer's report:
The authors responded to the reviewers' suggestions in a targeted manner.
I have no more questions.
As an extra word,  I hope to see the results of the authors' clinical trial of Triptolide for IBS
in the future.
Title: Triptolide attenuates irritable bowel syndrome via inhibiting ODC1
Version: 3 Date: 06 Jun 2023
Reviewer's report:
The authors responded to the reviewers' suggestions in a targeted manner.
I have no more questions.
As an extra word,  I hope to see the results of the authors' clinical trial of Triptolide for IBS
in the future.
Please review this paper.
user
Title: Triptolide attenuates irritable bowel syndrome via inhibiting ODC1
Version: 3 Date: 06 Jun 2023
Reviewer's report:
The authors responded to the reviewers' suggestions in a targeted manner.
I have no more questions.
As an extra word,  I hope to see the results of the authors' clinical trial of Triptolide for IBS
in the future.
assistant